IIT Delhi Launches MS in Healthcare Technology for Medical Professionals, Starting January 2025
The Indian Institute of Technology (IIT) Delhi has announced the launch of a new Master of Science (Research) in Healthcare […]
The Indian Institute of Technology (IIT) Delhi has announced the launch of a new Master of Science (Research) in Healthcare […]
The National Institute of Pharmaceutical Education and Research, Ahmedabad (NIPER-A), claims to have developed a new class of compounds for […]
Former Microsoft India Chairman Ravi Venkatesan, who helped build and expand Microsoft’s largest presence outside of the USA in India, […]
Health Level Seven International (HL7), one of the leaders in developing interoperability standards for healthcare IT has announced its decision […]
Ensure that laboratories are providing accurate testing results in vitamin D testing methodology. Dr JS Suri, Director-Dr Suri Lab When […]
Key to Increase Compliance in Patients with Chronic Disease and Reduce Cost of Treatment The term Tele-Triage represents one of […]
Citing significant variations in pediatric radiopharmaceutical doses and package inserts lacking pediatric doses, the authors of an article appearing in […]
Health Level Seven® International (HL7®) International have announced an agreement to create a complementary process to foster interoperability that will […]
[This article was published in the May 2011 issue of the eHEALTH Magazine (https://www.ehealthonline.org) ] The patient monitoring market is an expanding and profitable sector in the global healthcare industry.
As the CFO of Columbia Asia Hospitals, Jagannath MS, delivers healthcare through the best model of hospitals and medical excellence.
[This article was published in the April 2011 issue of the eHEALTH Magazine (https://www.ehealthonline.org) ] The integration of ICT into the health sector has globally empowered the status of health in recent years
Researchers at Imperial College London have discovered a protein that triggers rheumatoid arthritis.
Biotechnology company Biogen Idec has announced the introduction of TYSABRI (natalizumab) the first humanized, monoclonal antibody for the treatment of relapsing remitting MS in India.